ABRAXIS ONCOLOGY

Welcome to the Brand page for “ABRAXIS ONCOLOGY”, which is offered here for Pharmaceuticals for the treatment of cancer; pharmaceuticals, vascular targeting agents, and sensitizing agents for chemotherapy-resistant tumors; nanoparticles for drug delivery or imaging agent delivery sold as an integral component of drugs or imaging agents.

Its status is currently believed to be active. Its class is “Pharmaceuticals”. “ABRAXIS ONCOLOGY” is believed to be currently owned by “APP Pharmaceuticals LLC”.

Owner:
APP PHARMACEUTICALS LLC
Owner Details
Description:
Pharmaceuticals for the treatment of cancer; pharmaceuticals, vascular targeting agents, and sensitizing agents for chemotherapy-resistant tumors; nanoparticles for drug delivery or imaging agent delivery sold as an integral component of drugs or imaging agents
Categories: ANALGESICS